Research News for November 16, 2022
advertisement
- Promising Drug Candidate Identified for Type 1 Diabetes Prevention
- TYK2 inhibitor identifies as a promising drug candidate for preventing type 1 diabetes
- Role of HLA-DPrs3077 and HLA-DQrs3920 polymorphisms as risk factors for Type 1 Diabetes Mellitus
- Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development
- Insights into the Genetics and Signaling Pathways in Maturity-Onset Diabetes of the Young
- The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes
- Vitamin D Repletion and AA/EPA Intake in Children with Type 1 Diabetes: Influences on Metabolic Status
- B7-H4 Polymorphism Influences the Prevalence of Diabetes Mellitus and Pro-Atherogenic Dyslipidemia in Patients with Psoriasis
- Berberine Regulates GPX4 to Inhibit Ferroptosis of Islet β Cells
- Setting the Stage for Insulin Granule Dysfunction during Type-1-Diabetes: Is ER Stress the Culprit?
- Targeted delivery of harmine to xenografted human pancreatic islets promotes robust cell proliferation (Full text HTML)
- Pilot study in human healthy volunteers on the use of magnetohydrodynamics in needle-free continuous glucose monitoring (Full text HTML)
- Intelligent Control with Artificial Neural Networks for Automated Insulin Delivery Systems
- On demand regulation of blood glucose level by biocompatible oxidized starch-Con A nanogels for glucose-responsive release of exenatide
- A Microtube-Based Wearable Closed-Loop Minisystem for Diabetes Management (Full text HTML, PDF)
